​

XORTX Therapeutics Ownership | Who Owns XORTX Therapeutics?

OverviewChart

XORTX Therapeutics Ownership Summary

XORTX Therapeutics is owned by 0.01% institutional investors, 8.26% insiders, and 91.74% retail investors.

XRTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockXORTX Therapeutics0.01%8.26%91.74%
SectorHealthcare Stocks 35.74%11.83%52.43%
IndustryBiotech Stocks 36.05%11.82%52.13%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20261-83.33%47-99.98%-0.00%1-80.00%--
Dec 31, 2025620.00%230,697129.19%2422.69%566.67%--100.00%
Sep 30, 20255-28.57%100,65853.01%1013.75%3-50.00%1-
Jun 30, 20257250.00%65,78514486.47%8238633.83%6---100.00%
Mar 31, 20252-66.67%451-99.84%-0.00%--100.00%1-50.00%

XRTX Ownership FAQ

Who Owns XORTX Therapeutics?

XORTX Therapeutics shareholders are primarily institutional investors at 0.01%, followed by 8.26% insiders and 91.73% retail investors. The average institutional ownership in XORTX Therapeutics's industry, Biotech Stocks , is 36.05%, which XORTX Therapeutics falls below.

Does Blackrock own XORTX Therapeutics?

BlackRock is not among the top 10 institutional shareholders of XORTX Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools